Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2011-08-23
2011-08-23
Wax, Robert A (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C623S001120, C623S001420
Reexamination Certificate
active
08003122
ABSTRACT:
Medical devices may be utilized for local and regional therapeutic agent delivery. These therapeutic agents or compounds may reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the prevention of thrombosis. The drugs, agents, and/or compounds may also be utilized to treat specific disorders, including restenosis, vulnerable plaque, and atherosclerosis in type 2 diabetic patients. In regional delivery, liquid formulations may be desirable to increase the efficacy and deliverability of the particular drug. Various materials and coating methodologies may be utilized to maintain the agents or compounds on the medical device until delivered and positioned.
REFERENCES:
patent: 3576883 (1971-04-01), Neuworth
patent: 3576886 (1971-04-01), Neuworth
patent: 3862332 (1975-01-01), Barnhart et al.
patent: 3929992 (1975-12-01), Sehgal et al.
patent: 3959078 (1976-05-01), Guire
patent: 4350160 (1982-09-01), Kolesov et al.
patent: 4366819 (1983-01-01), Kaster
patent: 4368736 (1983-01-01), Kaster
patent: 4624257 (1986-11-01), Berggren et al.
patent: 4722906 (1988-02-01), Guire
patent: 4733665 (1988-03-01), Palmaz
patent: 4739762 (1988-04-01), Palmaz
patent: 4776337 (1988-10-01), Palmaz
patent: 4814470 (1989-03-01), Colin et al.
patent: 4857653 (1989-08-01), Colin et al.
patent: 4917090 (1990-04-01), Berggren et al.
patent: 4917091 (1990-04-01), Berggren et al.
patent: 4942184 (1990-07-01), Haugwitz et al.
patent: 4984060 (1991-01-01), Ohmi et al.
patent: 5059699 (1991-10-01), Kingston et al.
patent: 5200534 (1993-04-01), Rao
patent: 5202448 (1993-04-01), Carver et al.
patent: 5229172 (1993-07-01), Cahalan et al.
patent: 5229529 (1993-07-01), Ueno et al.
patent: 5234447 (1993-08-01), Kaster et al.
patent: 5248796 (1993-09-01), Chen et al.
patent: 5252805 (1993-10-01), Nakata et al.
patent: 5254580 (1993-10-01), Chen et al.
patent: 5272171 (1993-12-01), Ueda et al.
patent: 5274137 (1993-12-01), Nicolaou et al.
patent: 5278324 (1994-01-01), Kingston
patent: 5279949 (1994-01-01), Nair
patent: 5283253 (1994-02-01), Holton et al.
patent: 5294637 (1994-03-01), Chen et al.
patent: 5294997 (1994-03-01), Ogura et al.
patent: 5300638 (1994-04-01), Farina et al.
patent: 5308641 (1994-05-01), Cahalan et al.
patent: 5339906 (1994-08-01), Fox et al.
patent: 5350800 (1994-09-01), Verhoeven et al.
patent: 5350866 (1994-09-01), Holton et al.
patent: 5352805 (1994-10-01), Kingston et al.
patent: 5362831 (1994-11-01), Mongelli et al.
patent: 5380751 (1995-01-01), Chen et al.
patent: 5395850 (1995-03-01), Roth
patent: 5411984 (1995-05-01), Kingston et al.
patent: 5412092 (1995-05-01), Rey et al.
patent: 5415938 (1995-05-01), Cahalan et al.
patent: 5422364 (1995-06-01), Nicolaou et al.
patent: 5440056 (1995-08-01), Klein et al.
patent: 5516770 (1996-05-01), Waranis et al.
patent: 5837313 (1998-11-01), Ding et al.
patent: 5891845 (1999-04-01), Myers
patent: 5924997 (1999-07-01), Campbell
patent: 6099562 (2000-08-01), Ding et al.
patent: 6120536 (2000-09-01), Ding et al.
patent: 6136846 (2000-10-01), Rubinfeld et al.
patent: 6153252 (2000-11-01), Hossainy et al.
patent: 6241762 (2001-06-01), Shanley
patent: 6245026 (2001-06-01), Campbell et al.
patent: 6248363 (2001-06-01), Patel et al.
patent: 6293967 (2001-09-01), Shanley
patent: 6319943 (2001-11-01), Joshi et al.
patent: 6425898 (2002-07-01), Wilson et al.
patent: 6451339 (2002-09-01), Patel et al.
patent: 6458373 (2002-10-01), Quay et al.
patent: 6509370 (2003-01-01), Joshi-Hangal et al.
patent: 6515016 (2003-02-01), Hunter
patent: 6538020 (2003-03-01), Joshi-Hangal et al.
patent: 6667048 (2003-12-01), Lambert et al.
patent: 6753006 (2004-06-01), Desai
patent: 6764507 (2004-07-01), Shanley et al.
patent: 6828346 (2004-12-01), Joshi-Hangal et al.
patent: 6919370 (2005-07-01), Chen
patent: 7060709 (2006-06-01), Cooperstone et al.
patent: 2003/0087954 (2003-05-01), Palepu et al.
patent: 2003/0105156 (2003-06-01), Palepu et al.
patent: 2003/0170287 (2003-09-01), Prescott
patent: 2003/0187062 (2003-10-01), Zenoni
patent: 2003/0204239 (2003-10-01), Carlyle et al.
patent: 2003/0207936 (2003-11-01), Chen
patent: 2004/0106973 (2004-06-01), Johnson
patent: 2004/0167152 (2004-08-01), Rubino et al.
patent: 2004/0224003 (2004-11-01), Schultz
patent: 2005/0222191 (2005-10-01), Falotico et al.
patent: 2005/0272806 (2005-12-01), Falotico et al.
patent: 2010/0233236 (2010-09-01), Zhao
patent: 2010/0331816 (2010-12-01), Dadino et al.
patent: 041795 (1981-12-01), None
patent: 590267 (1993-07-01), None
patent: 0950386 (1999-10-01), None
patent: WO 93/10076 (1993-05-01), None
patent: WO 93/19763 (1993-10-01), None
patent: WO 93/23555 (1993-11-01), None
patent: WO 93/24476 (1993-12-01), None
patent: WO 94/00156 (1994-01-01), None
patent: WO 94/07876 (1994-04-01), None
patent: WO 94/07880 (1994-04-01), None
patent: WO 94/07881 (1994-04-01), None
patent: WO 94/07882 (1994-04-01), None
patent: WO 94/20089 (1994-09-01), None
patent: 98/33443 (1998-08-01), None
patent: WO 99/45918 (1999-09-01), None
patent: WO 00/71163 (2000-11-01), None
patent: WO 01/30319 (2001-05-01), None
patent: WO 02/43765 (2002-06-01), None
patent: WO 03/057208 (2003-07-01), None
patent: WO 2004/002182 (2003-12-01), None
patent: WO 2004/011000 (2004-02-01), None
patent: WO 2004/026182 (2004-04-01), None
patent: WO 2004/043510 (2004-05-01), None
patent: WO 2004/091506 (2004-10-01), None
patent: WO 2004/110302 (2004-12-01), None
wikipedia-sirolimus pp. 1-2 (http://en.wikipedia.org/wiki/Sirolimus).
wikipedia-sirolimus pp. 1-2 (http://en.wikipedia.org/wiki/Sirolimus): retrieved from online on Aug. 2, 2010.
U.S. Appl. No. 09/948,987.
Circulation: 84:11-299 Abstracts From the 64th Scientific Sessions (1991) (Lee).
Edelman, E. ,et al. “Pathobiologic Responses to Stenting”, American Journal of Cardiology, vol. 81, Issue 7, Suppl. 1 (Apr. 1998) pp. 4E-6E.
Fleischman, L., et al. “Ras-Transformed Cells: Altered Levels of phosphatidylinositol-4,5-Bisphosphate and Catabolites”, Reports (1986) pp. 407-410.
Franklin, S., et al. “Pharmacologic Prevention of Restenosis After Coronary Angioplasty: Review of the Randomized Clinical Trials”, Coronary Artery Disease, vol. 4, No. 3 (Mar. 1993) pp. 232-242.
Georg, G., et al.“Synthesis of Biologically Active Taxol Analogues With Modified Phenylisoserine Side Chains”, J. Medicinal Chemistry, vol. 35 (1992) pp. 4230-4237.
Mak and Topol, K., et al. “Clinical Trials to Prevent Restenosis After Percutaneous Coronary Revascularization”, Department of Cardiolg. Cleveland Clinical Foundation, Ohio pp. 255-288 (1991).
Marx, S., et al. “Rapamycin-FKBP Inhibits Cell Cycle Regulators of Proliferation in Vascular Smooth Muscle Cells”, Circulation Research, vol. 76(3) pp. 412-417 (1995).
Serruys, P., et al. “Evaluation of Ketanserin in the Prevention of Restenosis After Percutaneous Transluminal Coronary Angioplasty. A Multicenter Randomized Double-Blind Placebo-Controlled Trial”, American Heart Association, Circulation 88 (1993) pp. 1588-1601.
Shayesteh, L., et al. “PIK3CA is Implicated as an Oncogene in Ovarian Cancer”, Nature Genetics, vol. 21 (1999) pp. 99-102.
Steinberg, D., et al. “Beyond Cholesterol, Modifications of Low-Density Lipoprotein That Increase Its Atherogenicity”, vol. 320, No. 14, pp. 915-924 (1989).
Tanaka, H., et al., “Sustained Activation of Vascular Cells and Leukocytes the Rabbit Aorta After Balloon Injury”, Circulation, vol. 88, pp. 1788-1803 (1993).
Ajroldi, G., et al. “Fluoroelastomers-Dependence of Relaxation Phenomena on Composition”, Polymer (1989) vol. 30, p. 2180.
Anderson, T. J., et al., “The Effect of Cholesterol-Lowering and Antioxidant Therapy on Endothelium-Dependent Coronary Vasomotion”, The New England Journal of Medicine, vol. 332, No. 8, pp. 488-493, Feb. 23, 1995.
Bendeck, M., et al., “Smooth Muscle Cell Migration and Matrix Metalloprote
Barham Bethany
Cordis Corporation
Wax Robert A
LandOfFree
Device for local and/or regional delivery employing liquid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Device for local and/or regional delivery employing liquid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Device for local and/or regional delivery employing liquid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2681814